About this event
- Date and time Mon 17 Mar 2025 from 9:15am to 4:30pm
- Location Royal Society of Medicine
- Organised by Radiology
With changing practices driven by advances in technology, tracers and drug development, it is important to keep up to date with the evolving role of PET (Positron Emission Tomography) and how it can affect clinical pathways as well as research.
Join us for this annual meeting to explore the latest innovations in PET-CT technology. Discover how advancements in tracers and drug development are transforming dementia imaging, particularly with the emergence of disease-modifying treatments. Additionally, delve into the evolving role of PET-CT in prostate cancer imaging and cutting-edge cardiovascular research.
By attending, you will:
- Learn how total body PET-CT is changing clinical pathways and advancing research
- Gain a better understanding of the use and effects of disease-modifying drugs in Alzheimer’s disease and how they can impact patients and affect PET pathways
- Understand the impact of PSMA PET CT imaging in the staging of prostate cancer
- Gain a better understanding of the advances in cardiovascular PET research
Follow us on:
Tickets
Early Bird pricing available until 03 February 2025.
Member
| RSM Fellow | RSM Associate | RSM Retired Fellow | RSM Trainee | RSM Student |
|---|---|---|---|---|
| £50.00 | £30.00 | £30.00 | £30.00 | £10.00 |
Non - Member
| Consultant / GP / SAS Doctors | AHP / Nurse / Midwife | Trainee | Student |
|---|---|---|---|
| £95.00 | £50.00 | £50.00 | £30.00 |
Agenda
View the programme 17 March 2025
Registration, tea and coffee
Welcome and introduction
Dr George Petrides, Radiology Consultant, Newcastle Upon Tyne Hospitals
Session 1: Prostate cancer PET imaging
PSMA in the staging of prostate cancer: Radiologist and urologist perspectives
Professor Tara Barwick, Consultant in Radiology and Nuclear Medicine, Imperial College London and Mr Martin Connor, Urologist and Academic Clinical Lecturer, Imperial College London
Advances in prostate cancer imaging
Professor Rod Hicks, Melbourne Theranostic Innovation Centre, Professorial Fellow, The University of Melbourne and Adjunct Professor, Monash University
Panel discussion
Tea and coffee break
Session 2: Dementia
Clinical approaches to diagnosing Alzheimer's disease and the role of biomarkers in disease modifying therapies
Dr Bob Barber, Consultant Old Age Psychiatrist and Honorary Clinical Senior Lecturer, Newcastle
Setting up an amyloid PET service
Professor Vineet Prakash, Consultant in Nuclear Medicine, Royal Surrey County Hospital
Novel PET tracers for dementia
Professor John O’Brien, Professor of Old Age Psychiatry, University of Cambridge
Panel discussion
Lunch
Session 3: Cardiovascular imaging
PET in cardiovascular research
Professor Michelle Williams, Professor of Cardiovascular Imaging, University of Edinburgh
An update on PET in large vessel vasculitis
Dr Chirag Patel, Consultant Radiologist and Nuclear Medicine Physician, Leeds Teaching Hospitals NHS Trust
Panel discussion
Tea and coffee break
Session 4: Total body PET-CT
Total body PET-CT: A clinical perspective
Dr Thomas Wagner, Consultant in Nuclear Medicine, Royal Free Hospital London
Total body PET-CT: A research perspective
Professor Gary Cook, Professor of PET Imaging, King’s College London
My experience with total body PET-CT
Professor Rod Hicks
Panel discussion
Dr Amy Eccles, Professor Gary Cook, Dr Thomas Wagner, Professor Rod Hicks and Professor Michelle Williams
Close of meeting
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registrations will close on 16 March 2025 at 1:00am (GMT). Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.